In this study, in addition to our cohort, we extracted clinical and RNA sequencing data from the Multiple Myeloma Research Foundation (MMRF) CoMMpass study to assess the clinical significance of PRMT5. This evidence concerns the gene PRMT5 and AL amyloidosis.